Study Summary
This trial is to see if the Phasix Mesh implant prevents incisional hernias better than just using regular stitches.
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
0 Primary · 7 Secondary · Reporting Duration: 60-months
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
2 Treatment Groups
Primary Suture Closure
1 of 2
Phasix™ Mesh
1 of 2
Active Control
Experimental Treatment
477 Total Participants · 2 Treatment Groups
Primary Treatment: Phasix™ Mesh · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Who else is applying?
What state do they live in?
California | 100.0% |
What site did they apply to?
University of California San Francisco | 100.0% |
What portion of applicants met pre-screening criteria?
Met criteria | 100.0% |
Frequently Asked Questions
Are additional volunteers sought for this trial?
"Affirmative. Clinicaltrials.gov indicates that the recruitment for this trial is ongoing, with registration starting on December 12th 2019 and being updated as recently as October 24th 2022. 477 participants are required from 17 sites around the nation." - Anonymous Online Contributor
What is the current enrollment rate for participants in this research project?
"This medical trial necessitates 477 participants who qualify for the set inclusion criteria to join. Potential candidates can locate participating sites in both Peoria, Illinois (OSF Saint Francis Medical Center) and Omaha, Nebraska (Nebraska Medical Centre)." - Anonymous Online Contributor
How many facilities are presently conducting this research trial?
"Presently, 17 sites are running the clinical trial. These locations span from Peoria to Omaha and Bronx as well as 14 other locales. It is prudent for participants to select a site that minimizes their travel burden if they decide to enroll." - Anonymous Online Contributor